[Place of urapidil in the treatment of hypertensive crises from the standpoint of clinical pharmacology and evidence-based medicine]

Kardiologiia. 2013;53(12):79-82.
[Article in Russian]
No abstract available

Publication types

  • Review

MeSH terms

  • Antihypertensive Agents / pharmacokinetics
  • Antihypertensive Agents / therapeutic use
  • Blood Pressure / drug effects*
  • Clinical Trials as Topic
  • Evidence-Based Medicine
  • Humans
  • Hypertension, Malignant / classification
  • Hypertension, Malignant / drug therapy*
  • Hypertension, Malignant / physiopathology
  • Infusions, Parenteral
  • Piperazines* / pharmacokinetics
  • Piperazines* / therapeutic use
  • Treatment Outcome

Substances

  • Antihypertensive Agents
  • Piperazines
  • urapidil